<DOC>
	<DOCNO>NCT00551720</DOCNO>
	<brief_summary>The purpose study develop evaluate brief , clinic-based smoking cessation treatment HIV+ population . We compare two treatment , brief advice follow-up plus nicotine patch treatment ( Standard Care ; SC ) brief advice follow-up , nicotine patch , addition tailor motivational intervention behavioral skill counsel smoke cessation ( Motivationally-Enhanced ; ME ) , randomize control trial . We hypothesize HIV+ participant receive ME demonstrate great biochemically verify smoking abstinence rate 6-month follow-up receive SC control treatment . All study participant offer use nicotine patch .</brief_summary>
	<brief_title>Motivation Patch Treatment HIV-positive Smokers</brief_title>
	<detailed_description>Cigarette smoke highly prevalent among HIV+ individual , pose unique health risk , impact HAART-therapy effectiveness , possibly alter course disease . To knowledge , Motivation Patch Treatment HIV-Positive Individuals ( Positive PATHS ) first NIH-funded smoking cessation intervention design motivate HIV+ smoker quit . Participants refer physician eight Immunology clinic New England randomize receive either brief , two-session intervention ( Standard Care ; SC ) model PHS guideline , intensive , four-session motivational counseling intervention ( Motivational-Enhancement ; ME ) . All physician participate trial train study eligibility criterion , well basic smoke cessation counseling strategy ( base PHS guideline ) . Interested individual refer study , study researcher explain detail study obtain informed consent . Participants assist complete baseline assessment via laptop computer , randomize receive either brief intervention ( 2-sessions ) design reflect standard care outpatient hospital setting model PHS guideline ( standard care ; SC ) intensive ( 4-session ) motivational counseling intervention ( motivational enhancement ; ME ) , intervention provide 8-weeks nicotine replacement ( patch ; NRT ) participant willing set quit date . Follow-up assessment , include biochemical verification self-reported quitter ( via carbon monoxide measurement ) conduct 2 , 4 , 6 month baseline . This study among first examine health effect deliver smoke cessation intervention HIV+ population , result implication treatment clinical care setting .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<criteria>Be receive care HIV one participate immunology clinic Be 18 year old old Be current ( past 7 day ) cigarette smoker Speak English Spanish Are pregnant nursing Have uncontrolled hypertension Use form tobacco like cigar chew tobacco use anything else help quit smoke Are allergic nicotine patch skin condition like eczema psoriasis make unable use patch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>HIV</keyword>
	<keyword>HIV positive</keyword>
	<keyword>AIDS</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>smoking</keyword>
	<keyword>smoke counseling</keyword>
</DOC>